With Iris Pharma, you can mix-and-match stand-alone services or choose global support to test new ocular drugs and devices in humans during clinical development.
Iris Pharma’s clinical operations staff includes experienced project leaders and trained Clinical Research Associates (CRA). Our staff excels at all stages of study operations:
Iris Pharma’s medical writers include staff with experience as ophthalmologists, pharmacists, scientists, and marketing experts, in addition to renowned external medical writing partners. We maintain close ties with international opinion leaders in ophthalmology and pharmacology as well.
The writing and editing services we offer our clients include:
Iris Pharma alleviates the difficulties of leading a multinational trial by coordinating:
All activities are performed under the European clinical trial directive (2001/20/CE) and local laws.
Last year, Iris Pharma facilitated 143 regulatory submissions and approvals across 27 countries in Europe.
A single partner for clinical trials and a central laboratory give our clients the benefit of real-time and integrated data. To facilitate this, we help with the following services for all phases of ophthalmic clinical trials:
According to the requirements of a particular study, we select the most effective subcontracting solution among our different partners, consisting of highly qualified and experienced data managers and statisticians.
We can collect data in a traditional paper Case Report Form (CRF), or from an electronic Case Report Form (eCRF). In the case of eCRF, electronical clinical data capture (EDC) is performed and clinical trial data are electronically submitted to a remote database, allowing real-time data availability.
